CERKALIS BIO Trademark

Research, design and development services; scientific and medical research and development; product research and development; pharmaceutical research and development; biotechnology research and development; biological, clinical and medical research; industrial research, development and testing services; scientific and technological services; scientific research; clinical trials; laboratory research and analysis; chemical and biochemical analysis services; provision of information and data relating to scientific and technological research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in the field of scientific research and biotechnology; design and development of medical technology; analysis of technical data; research and development in the field of small molecule therapeutics; research and development in the field of targeted protein degrader drugs; drug discovery, pharmaceutical drug development, and drug validation services in the field of targeted disease-causing or disease-associated protein degradation; medical and pharmaceutical research services in relation to protein degradation; research and development of platform technology, namely, biotherapeutic platforms for use in manufacturing pharmaceuticals and therapeutics in the pharmaceutical and biotechnology fields

Pharmaceutical, medicinal and therapeutic preparations for human and veterinary use; pharmaceutical and therapeutic preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases and genetic disorders; pharmaceutical products and preparations; medicinal preparations and substances; diagnostic agents, preparations and substances for medical purposes; chemical preparations for pharmaceutical use; biological preparations for medical purposes; biologics for medical purposes; biologics for the treatment of cancer, autoimmune and chronic diseases; biotechnological preparations for medical purposes; vaccines; reagents for medical purposes; bispecific small molecules that mediate targeted protein degradation through the ubiquitin proteasome system for medical purposes; pharmaceutical and therapeutic preparations for modulating protein degradation pathways; pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases and genetic disorders